Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Egyptian Drug Price Reform: New Trade Barrier Or Demand Driver?

This article was originally published in The Pink Sheet Daily

Executive Summary

The new drug pricing regime, a streamlined registration process and the government's initiative to widen health insurance coverage, could help drive up domestic demand for pharmaceutical products, especially for branded generics.

You may also be interested in...



Pfizer, Merck Execs Share Emerging Markets Strategies - Windhover's Pharmaceutical Strategic Alliances Conference (Part 1 of 2)

NEW YORK - Emerging markets will account for almost half of the global pharmaceutical market growth through 2014, according to IMS Health VP Rob Arnold

Actavis Eyes Acquisitions In The Middle East And Niche Products In The U.S.

Possibly acquiring development expertise in biosimilars from the Swiss firm BioPartners is one of several strategic moves that newly appointed chief executive Claudio Albrecht is now making at the generics company Actavis

GSK’s Strategy in Emerging Markets: Scale, Diversification and Access

Branded products are key to emerging markets, where they tend to have long lifecycles that extend well beyond patent expiration, GlaxoSmithKline's president of emerging markets Abbas Hussain told investors at a Sanford F. Bernstein conference May 6

Related Content

Topics

UsernamePublicRestriction

Register

PS071375

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel